sobuzoxane has been researched along with Hematologic Neoplasms in 2 studies
sobuzoxane: used in treatment of leukemia L1210
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sobuzoxane has an effect to protect against doxorubicin cardiotoxicity." | 2.40 | [Oral antitumor drugs for hematological malignancies]. ( Ohnishi, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, AK | 1 |
| Escargueil, AE | 1 |
| Skladanowski, A | 1 |
| Ohnishi, K | 1 |
2 reviews available for sobuzoxane and Hematologic Neoplasms
| Article | Year |
|---|---|
Catalytic topoisomerase II inhibitors in cancer therapy.
Topics: Aclarubicin; Antineoplastic Agents; Breast Neoplasms; DNA Topoisomerases, Type II; Enzyme Inhibitors | 2003 |
[Oral antitumor drugs for hematological malignancies].
Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; H | 1999 |